| Dr Joseph Anthony Couvillon, MD | |
|
1840 Amherst St, Winchester, VA 22601-2808 | |
| (540) 536-8750 | |
| (540) 536-8827 |
| Full Name | Dr Joseph Anthony Couvillon |
|---|---|
| Gender | Male |
| Speciality | Radiology - Vascular & Interventional Radiology |
| Location | 1840 Amherst St, Winchester, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053517516 | NPI | - | NPPES |
| 14P7S | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | ME105648 (Florida) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | ME 105648 (Florida) | Secondary |
| Entity Name | Professional Services Of Holy Cross |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487692828 PECOS PAC ID: 3779516992 Enrollment ID: O20050916000745 |
News Archive
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).
Humana's CEO says he does not regret sending Medicare customers a letter warning that health care reform could hurt their benefits. The letters caused government officials to probe whether the insurer violated federal regulations in September.
› Verified 3 days ago
| Entity Name | Ellis Bandt Birkin Kollins & Wong Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578584678 PECOS PAC ID: 4486568946 Enrollment ID: O20100115000415 |
News Archive
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).
Humana's CEO says he does not regret sending Medicare customers a letter warning that health care reform could hurt their benefits. The letters caused government officials to probe whether the insurer violated federal regulations in September.
› Verified 3 days ago
| Entity Name | Greensboro Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035999 PECOS PAC ID: 8729074901 Enrollment ID: O20200812000209 |
News Archive
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).
Humana's CEO says he does not regret sending Medicare customers a letter warning that health care reform could hurt their benefits. The letters caused government officials to probe whether the insurer violated federal regulations in September.
› Verified 3 days ago
| Entity Name | Coastal Radiology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144270307 PECOS PAC ID: 8224002696 Enrollment ID: O20210325000228 |
News Archive
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).
Humana's CEO says he does not regret sending Medicare customers a letter warning that health care reform could hurt their benefits. The letters caused government officials to probe whether the insurer violated federal regulations in September.
› Verified 3 days ago
| Entity Name | Golden State Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144872052 PECOS PAC ID: 1254761315 Enrollment ID: O20220412003003 |
News Archive
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).
Humana's CEO says he does not regret sending Medicare customers a letter warning that health care reform could hurt their benefits. The letters caused government officials to probe whether the insurer violated federal regulations in September.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Anthony Couvillon, MD Po Box 880, Lima, OH 45802-0880 Ph: (727) 286-8929 | Dr Joseph Anthony Couvillon, MD 1840 Amherst St, Winchester, VA 22601-2808 Ph: (540) 536-8750 |
News Archive
The U.S. is experiencing another surge of covid-19, particularly in Southern states where vaccination rates are generally lower than in other regions. But partisan fights rage on over what role government should play in trying to tamp down the highly contagious delta variant.
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).
Humana's CEO says he does not regret sending Medicare customers a letter warning that health care reform could hurt their benefits. The letters caused government officials to probe whether the insurer violated federal regulations in September.
› Verified 3 days ago
Yusuf Tahiri Akpolat, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8750 | |
Christine E. Huxol, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8750 Fax: 540-536-8827 | |
Kiarash Jahed, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8750 Fax: 540-536-8827 | |
Dr. David Kent Harry, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8750 | |
Dr. Curtis Jeffrey Thwing, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8750 | |
Nabeel Arastu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8750 |